FDA seeks public input on regulating generative-AI medical devices
The US Food and Drug Administration has published a discussion paper inviting feedback on how to regulate generative-AI-enabled medical devices, with submissions due by a set deadline. The move comes as thousands of studies on AI tools in clinical medicine are published yearly and more than 230 million people weekly ask chatbots health-related questions.